Yüklüyor......
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
AIMS: It is recommended to perform atrial fibrillation ablation with continuous anticoagulation. Continuous apixaban has not been tested. METHODS AND RESULTS: We compared continuous apixaban (5 mg b.i.d.) to vitamin K antagonists (VKA, international normalized ratio 2–3) in atrial fibrillation patie...
Kaydedildi:
| Yayımlandı: | Eur Heart J |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6110196/ https://ncbi.nlm.nih.gov/pubmed/29579168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehy176 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|